Agency Forms Undergoing Paperwork Reduction Act Review, 68887 [E7-23633]

Download as PDF 68887 Federal Register / Vol. 72, No. 234 / Thursday, December 6, 2007 / Notices mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Comments submitted in response to this notice will be summarized and included in the Agency’s subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Proposed Project Dated: November 29, 2007. Carolyn M. Clancy, Director. [FR Doc. 07–5950 Filed 12–05–07; 8:45 am] Gonococcal Isolate Surveillance Project (GISP)—Revision—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Background and Brief Description CDC is requesting a 3-year revision with change for this project. The objectives of GISP are to monitor trends in antimicrobial susceptibility of strains of Neisseria gonorrhoeae in the U.S. and characterize resistant isolates. GISP provides critical surveillance for antimicrobial resistance, allowing for informed treatment recommendations. This project began in 1986 as a voluntary surveillance project and has involved 5 regional laboratories and 30 publicly-funded, sexually transmitted disease (STD) clinics around the country. The STD clinics submit up to 25 gonococcal isolates per month to the regional laboratories, which measure Centers for Disease Control and Prevention [30Day–08–0307] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an e- susceptibility to a panel of antibiotics. Limited demographic and clinical information corresponding to the isolates are submitted directly by the STD clinics to CDC. During 1986–2006, GISP has demonstrated the ability to effectively achieve its objectives. The emergence of resistance in the United States to penicillin, tetracyclines, and now fluoroquinolones was identified through GISP and makes ongoing surveillance critical. Increased prevalence of fluoroquinolone-resistant N. gonorrhoeae (QRNG) as seen in GISP data has prompted the CDC to update the treatment recommendations for gonorrhea in the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2006 and to release an MMWR article stating the CDC no longer recommends fluoroquinolones for treatment of gonococcal infections (CDC, MMWR, Vol.56, No.14, 332–336). Respondents are paid by Federal funds through the CDC Comprehensive STD Prevention Systems, Prevention of STDRelated Infertility, and Syphilis Elimination Grant (CSPS), for their participation in GISP network. The estimated annualized burden for this data collection is 8,628 hours. ESTIMATED ANNUALIZED BURDEN HOURS No. of respondents No. of responses per respondent Avg. burden per response (in hours) Type of respondent Form name Clinic .................................................................... Laboratory ............................................................ Form 1 ................................................. Form 2 ................................................. Form 3 ................................................. 30 5 5 240 1,452 48 11/60 1 12/60 Total .............................................................. .............................................................. 40 .......................... .......................... Dated: November 28, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer. [FR Doc. E7–23633 Filed 12–5–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on PROD1PC66 with NOTICES [60Day–08–0263] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the VerDate Aug<31>2005 18:57 Dec 05, 2007 Jkt 214001 Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Requirements for a Special Permit to Import Cynomolgus, African Green, or Rhesus Monkeys into the United States—Extension—National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC is requesting OMB approval to continue its data collection, ‘‘Requirements for a Special Permit to E:\FR\FM\06DEN1.SGM 06DEN1

Agencies

[Federal Register Volume 72, Number 234 (Thursday, December 6, 2007)]
[Notices]
[Page 68887]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-23633]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-08-0307]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Gonococcal Isolate Surveillance Project (GISP)--Revision--National 
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a 3-year revision with change for this project. 
The objectives of GISP are to monitor trends in antimicrobial 
susceptibility of strains of Neisseria gonorrhoeae in the U.S. and 
characterize resistant isolates. GISP provides critical surveillance 
for antimicrobial resistance, allowing for informed treatment 
recommendations.
    This project began in 1986 as a voluntary surveillance project and 
has involved 5 regional laboratories and 30 publicly-funded, sexually 
transmitted disease (STD) clinics around the country. The STD clinics 
submit up to 25 gonococcal isolates per month to the regional 
laboratories, which measure susceptibility to a panel of antibiotics. 
Limited demographic and clinical information corresponding to the 
isolates are submitted directly by the STD clinics to CDC.
    During 1986-2006, GISP has demonstrated the ability to effectively 
achieve its objectives. The emergence of resistance in the United 
States to penicillin, tetracyclines, and now fluoroquinolones was 
identified through GISP and makes ongoing surveillance critical. 
Increased prevalence of fluoroquinolone-resistant N. gonorrhoeae (QRNG) 
as seen in GISP data has prompted the CDC to update the treatment 
recommendations for gonorrhea in the CDC's Sexually Transmitted 
Diseases Treatment Guidelines, 2006 and to release an MMWR article 
stating the CDC no longer recommends fluoroquinolones for treatment of 
gonococcal infections (CDC, MMWR, Vol.56, No.14, 332-336). Respondents 
are paid by Federal funds through the CDC Comprehensive STD Prevention 
Systems, Prevention of STD-Related Infertility, and Syphilis 
Elimination Grant (CSPS), for their participation in GISP network. The 
estimated annualized burden for this data collection is 8,628 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     No. of        Avg. burden
         Type of respondent                  Form name              No. of       responses per     per response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Clinic..............................  Form 1.................               30              240            11/60
Laboratory..........................  Form 2.................                5            1,452                1
                                      Form 3.................                5               48            12/60
                                     ---------------------------------------------------------------------------
    Total...........................  .......................               40  ...............  ...............
----------------------------------------------------------------------------------------------------------------


    Dated: November 28, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer.
[FR Doc. E7-23633 Filed 12-5-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.